These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1720478)

  • 1. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
    Pereira-Miguel JM; Correa-Nunes A; Rocha-Gonçalves F; Mariano-Pego G
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and tolerability of isradipine in the treatment of mild-to-moderate hypertension in young and elderly patients.
    Batlouni M; Armaganijan D; Ghorayeb N; Magliano MF
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S53-7. PubMed ID: 1376836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
    Amir M; Cristal N; Bar-On D; Loidl A
    Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
    Yodfat Y; Bar-On D; Amir M; Cristal N
    J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
    Lüscher TF; Waeber B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Farragi D
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R; Svensson A; Dahlöf B; Hansson L
    Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies on isradipine in the management of adult hypertensive patients at Moi University Teaching Hospital, Eldoret, Kenya.
    Lore W; Anjichi GM
    East Afr Med J; 1992 Feb; 69(2):69-73. PubMed ID: 1387077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.